Female with hypoactive sexual desire?

-Topical testosterone has been shown to work.

This  patient  meets  the  criteria  for  hypoactive  sexual  desire  disorder  (HSDD).  The  incidence  of  this condition is variable based on the age, life stage, and culture of the patient, but is estimated to be present in about 5%–15% of the adult female population. This diagnosis includes two components: (1) recurrent deficiency  or  absence  of  sexual  desire  or  receptivity  to  sexual  activity,  and  (2)  distress  about  such  a deficiency. In menstruating women, oral estrogen and oral sildenafil have not been shown to be superior to placebo. Cognitive-behavioral therapy has been shown to be helpful for other sexual dysfunctions, but not with HSDD. Topical testosterone, in either patch or gel form, has shown consistent improvements in arousal, desire, fantasy, orgasm, and overall satisfaction in cases of HSDD.

Ref:     Parish SJ: From whence comes HSDD? J Fam Pract 2009;58(7 Suppl Hypoactive):S16-S21 2) American College of Obstetricians and Gynecologists Committee on Practice Bulletins–Gynecology: ACOG Practice Bulletin No. 119: Female sexual dysfunction. Obstet Gynecol 2011;117(4):996-1007. 3) Simon JA. Opportunities for intervention in HSDD. J Fam Pract. 2009;58(7 Suppl Hypoactive):S26-30. Review.” ABFM

print